Related references
Note: Only part of the references are listed.Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
Jiajia Du et al.
FRONTIERS IN ONCOLOGY (2021)
Role of α-Synuclein Regions in Nucleation and Elongation of Amyloid Fiber Assembly
Jose Gallardo et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Structural Characterization of Individual α-Synuclein Oligomers Formed at Different Stages of Protein Aggregation by Atomic Force Microscopy-Infrared Spectroscopy
Lei Zhou et al.
ANALYTICAL CHEMISTRY (2020)
A short motif in the N-terminal region of α-synuclein is critical for both aggregation and function
Ciaran P. A. Doherty et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis
Jing Zhou et al.
CELL DEATH & DISEASE (2018)
Association between Parkinson's disease and risk of colorectal cancer
Xin Xie et al.
PARKINSONISM & RELATED DISORDERS (2017)
Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review
M. De Hert et al.
ACTA PSYCHIATRICA SCANDINAVICA (2016)
DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology
Ricardo Taipa et al.
BRAIN (2016)
The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis
Rong Ye et al.
PLOS ONE (2016)
Thermal protein unfolding by differential scanning calorimetry and circular dichroism spectroscopy Two-state model versus sequential unfolding
Joachim Seelig et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2016)
Structure based aggregation studies reveal the presence of helix-rich intermediate during alpha-Synuclein aggregation
Dhiman Ghosh et al.
SCIENTIFIC REPORTS (2015)
The associations between Parkinson's disease and cancer: the plot thickens
Danielle D. Feng et al.
TRANSLATIONAL NEURODEGENERATION (2015)
Sequence and Membrane Determinants of the Random Coil-Helix Transition of α-Synuclein
Sowmya B. Lokappa et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
Nikolai Lorenzen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Drug-induced parkinsonism
Jose Lopez-Sendon et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Properties of native brain α-synuclein
Jacqueline Burre et al.
NATURE (2013)
Drug-Induced Parkinsonism
Hae-Won Shin et al.
JOURNAL OF CLINICAL NEUROLOGY (2012)
Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins
Daniel Agudelo et al.
PLOS ONE (2012)
The association between Parkinson's disease and melanoma
Tianhong Pan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Parkinson's disease and cancer risk: a systematic review and meta-analysis
Archna Bajaj et al.
CANCER CAUSES & CONTROL (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Drug induced parkinsonism: a common cause of parkinsonism in older people
B. Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Characterization of doxorubicin binding site and drug induced alteration in the functionally important structural state of oxyhemoglobin
Shahper N. Khan et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
A. Petitjean et al.
ONCOGENE (2007)
Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from α-synuclein mutants
Martijn E. van Raaij et al.
BIOPHYSICAL JOURNAL (2006)
The aggregation and fibrillation of α-synuclein
Anthony L. Fink
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Expression of α-, β-, and γ-synuclein in glial tumors and medulloblastomas
KM Fung et al.
ACTA NEUROPATHOLOGICA (2003)
Chemotherapy-induced parkinsonism responsive to levodopa: An underrecognized entity
C Chuang et al.
MOVEMENT DISORDERS (2003)
Cancer risk and the ATM gene: A continuing debate
KK Khanna
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
